• Early Life Adversity, Oxytocin, and Innate Fear

  2026-09-10

  This 2026 Communications Biology study links early life adversity to impaired looming-evoked defensive behavior in mice and identifies deficient oxytocin signaling in the superior colliculus as a mechanistic pathway. Its combination of developmental stress modeling, circuit analysis, receptor manipulation, and intranasal oxytocin rescue provides a framework for studying how early experience alters innate threat processing.

• ALC-0315 LNP Mixing: Workflow and Troubleshooting

  2026-09-10

  Build more reproducible mRNA lipid nanoparticles with ALC-0315 by treating mixing as a formulation variable, not merely a transfer step. This workflow connects stock handling, flow regime, physicochemical QC, and biological testing to improve the relevance of bench-scale results for therapeutic mRNA delivery.

• Triptolide and Transcriptional Stress

  2026-09-09

  Triptolide (PG490) is more than a cytotoxic natural product: it is a powerful probe of transcriptional stress, immune signaling, and tissue-barrier biology. This article connects its CDK7–RNAPII mechanism with new acute pancreatitis findings to improve assay design and interpretation.

• VX-745: p38α MAPK Inhibitor Workflows

  2026-09-09

  VX-745 combines nanomolar p38α inhibition with practical utility across cytokine, oncology, aging, and arthritis research. This guide converts its biochemical profile into reproducible cell-assay workflows, mechanistic controls, and troubleshooting strategies.

• NF 449: From P2X1 Blockade to Assay Design

  2026-09-08

  NF 449 is a potent purinergic receptor antagonist for resolving P2X1-dependent platelet signaling. This guide interprets potency across recombinant, native-cell, and thrombosis models while translating the evidence into better platelet assay design.

• Fucoidan and Cancer Plasticity: A Translational Roadmap

  2026-09-08

  Fucoidan is more than a broadly described marine polysaccharide: its apoptosis, angiogenesis, and immune-modulating activities create a useful framework for translational oncology. This article connects those findings with cancer-cell plasticity research and outlines a disciplined path from mechanistic hypothesis to reproducible model validation.

• Triptolide (PG490) Experimental Workflow

  2026-09-07

  Triptolide (PG490) is a nanomolar transcriptional perturbagen for cancer, immune, and inflammatory research. This guide translates its RNAPII, IL-2, NF-κB, MMP, and AhR–HSF1 applications into practical workflows, controls, and troubleshooting strategies.

• CB-839 Workflow for Glutamine Metabolism

  2026-09-07

  CB-839 (Telaglenastat) provides a selective, reversible way to test whether GLS1-dependent glutaminolysis supports tumor-cell growth, metabolic fitness, or stress adaptation. This workflow connects dose-response pharmacology with metabolite, apoptosis, autophagy, and RNA-regulatory readouts for stronger preclinical cancer drug evaluation.

• Ajugol, Mitophagy, and Pyroptosis in Gouty Arthritis

  2026-09-05

  The reference study identifies impaired PINK1/Parkin-dependent mitophagy as a mechanistic link between PI3K/Akt/mTOR signaling and chondrocyte pyroptosis in acute gouty arthritis. Using computational analysis, human chondrocyte models, pharmacological perturbation, and MSU-induced mice, the authors show that ajugol protects cartilage by restoring mitochondrial quality control and limiting NLRP3 inflammasome activation.

• Recombinant Human Oncostatin M in Fibrosis Assays

  2026-09-04

  Recombinant Human Oncostatin M provides a defined cytokine perturbation for dissecting inflammatory and fibroproliferative circuits. This guide connects rh-Oncostatin M with mast cell–mesothelial crosstalk research while separating established findings from testable assay hypotheses.

• From NEXMIF Biology to qPCR Translation

  2026-09-04

  A translational framework for using targeted qPCR to validate NEXMIF dosage biology, connect transcriptomic findings with neuronal phenotypes, and build more reproducible gene expression workflows with HotStart™ Universal 2X Green qPCR Master Mix.

• Pam3CSK4 TFA for TLR1/2 Assays

  2026-09-03

  Pam3CSK4 TFA provides a defined, tunable trigger for separating TLR1/2-driven cytokine responses from the broader complexity of bacterial stimulation. This guide translates maternal–neonatal biomarker findings into practical assay design, stock handling, controls, optimization, and translational workflows.

• Bifendate (DDB): Translational Guardrails for Liver Research

  2026-09-03

  Bifendate (DDB) is best understood as a context-dependent hepatoprotection agent rather than a simple lipid-lowering compound. This thought-leadership guide connects its autophagy-related mechanisms, lipid phenotypes, formulation requirements, and CYP3A4-linked interaction risk to a more rigorous translational strategy.

• Macrophage EV miR-660 Drives Breast Cancer Metastasis

  2026-09-02

  The reference study identifies a tumor-promoting communication route in which tumor-associated macrophage extracellular vesicles deliver miR-660 to breast cancer cells, suppressing KLHL21 and activating the IKKβ/NF-κB p65 axis. Its combination of tissue analysis, extracellular-vesicle co-culture, molecular perturbation, and mouse metastasis experiments provides a mechanistic framework for studying macrophage-driven dissemination.

• RNA G-Quadruplexes Shape TDP-43 Toxicity

  2026-09-02

  Oldani and colleagues show that RNA G-quadruplexes directly influence TDP-43 aggregation, intracellular distribution, and toxicity across biochemical, yeast, HEK293T, and motor-neuron-like cell models. The study supports structure-directed investigation of TDP-43 proteostasis while emphasizing that RNA G-quadruplex mechanisms should not be assumed to match DNA-focused stabilization strategies.

8481 records 1/566 page Next 12345 下5页 Last page